CSL-Ltd-CSLAX-Deep-dive-into-Pipeline-A12-to-Target-Price.pdf
This is a recently released Goldman Sachs report detailing the current R&D landscape for CSL. It provides the rational behind their $312 target price. Of course, with all broker reports you have to take them with a grain of salt. However, they explore each of the 15 projects in/near active development, assessing the data and the likely regulatory pathway and financial impact. Awesome read for anyone wanted a breakdown of the underlying molecules, the target markets and the overall opportunities. I feel sorry for the intern Riashad Monjur, who gets a brief shoutout for probably writing the whole thing. As usual DYOR.
CSL-Ltd-CSLAX-Deep-dive-into-Pipeline-A12-to-Target-Price.pdfThis...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$279.92 |
Change
0.740(0.27%) |
Mkt cap ! $135.2B | |||
| Open | High | Low | Value | Volume |
| $278.87 | $280.30 | $278.20 | $122.2M | 436.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1763 | $279.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $279.99 | 400 | 1 |
View Market Depth
| Last trade - 16.10pm 13/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$279.87 |
Change
0.740 ( 0.03 %) |
||||
| Open | High | Low | Volume | ||
| $278.83 | $280.30 | $278.29 | 57662 | ||
| Last updated 15.59pm 13/05/2024 ? | |||||
| CSL (ASX) Chart |